BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 3066670)

  • 1. Construction, purification and biological activities of recombinant human interleukin-2 analogs.
    Boone T; Chazin V; Kenney W; Swanson E; Altrock B
    Dev Biol Stand; 1988; 69():157-68. PubMed ID: 3066670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of site-specific mutations on biologic activities of recombinant human IL-6.
    Snouwaert JN; Kariya K; Fowlkes DM
    J Immunol; 1991 Jan; 146(2):585-91. PubMed ID: 1987278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on fermentation conditions and purification of mutant human interleukin-2 expressed in Pichia pastoris].
    Liu Y; Su C; Hu YH; Ouyang KQ; Cai SX
    Sheng Wu Gong Cheng Xue Bao; 2005 May; 21(3):430-4. PubMed ID: 16108369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the biological activities of human recombinant interleukin-2(125) and native interleukin-2.
    Doyle MV; Lee MT; Fong S
    J Biol Response Mod; 1985 Feb; 4(1):96-109. PubMed ID: 3920358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effective synthesis and cloning of the human interleukin-2 gene and its analog: expression of the interleukin-2 gene in E. coli cells].
    Daniliuk NK; Seregin SV; Siniakov AN; Serpinskiĭ OI; Babkina IN; Urmanova MA; Riabinin VA; Pozdniakov SG
    Bioorg Khim; 1991 Jun; 17(6):779-88. PubMed ID: 1776962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression in Escherichia coli of fully active recombinant human IL 1 beta: comparison with native human IL 1 beta.
    Tocci MJ; Hutchinson NI; Cameron PM; Kirk KE; Norman DJ; Chin J; Rupp EA; Limjuco GA; Bonilla-Argudo VM; Schmidt JA
    J Immunol; 1987 Feb; 138(4):1109-14. PubMed ID: 2949012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological and receptor-binding activities of human interleukin-2 mutated at residues 20Asp, 125Cys or 127Ser.
    Xu D; Eckenberg R; Moreau JL; Liu XY; Thèze J; Bertoglio J
    Eur Cytokine Netw; 1995; 6(4):237-44. PubMed ID: 8789289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human interleukin 1 alpha: purification and biological characterization.
    Gubler U; Chua AO; Stern AS; Hellmann CP; Vitek MP; DeChiara TM; Benjamin WR; Collier KJ; Dukovich M; Familletti PC
    J Immunol; 1986 Apr; 136(7):2492-7. PubMed ID: 3485152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of synthetic human interleukin-10 gene and its mutant variants in Escherichia coli cells].
    Ptitsyn LR; Al'tman IB; Gurov MV
    Bioorg Khim; 1998 Jan; 24(1):48-57. PubMed ID: 9551202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamine and tetrapeptide repeat variations affect the biological activity of different mouse interleukin-2 alleles.
    Matesanz F; Alcina A
    Eur J Immunol; 1996 Aug; 26(8):1675-82. PubMed ID: 8765005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression and characterization of recombinant human fusion protein IL-6/IL-2 (CH925).
    Zhao C; Tang P; Wang J; Mao N; Jiang F; Li X; Liu X; Zhang M; Ren Y; Du D
    Stem Cells; 1994 May; 12(3):339-47. PubMed ID: 8075595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of multiple lymphoid and recombinant human interleukin-2 preparations.
    Thurman GB; Maluish AE; Rossio JL; Schlick E; Onozaki K; Talmadge JE; Procopio AD; Ortaldo JR; Ruscetti FW; Stevenson HC
    J Biol Response Mod; 1986 Feb; 5(1):85-107. PubMed ID: 3514800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and co-cytokine function of murine thioredoxin/adult T cell leukaemia-derived factor (ADF).
    Blum H; Röllinghoff M; Gessner A
    Cytokine; 1996 Jan; 8(1):6-13. PubMed ID: 8742061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of recombinant forms of murine Tcl1 proteins.
    Du Bois GC; Song SP; Kulikovskaya I; Rothstein JL; Germann MW; Croce CM
    Protein Expr Purif; 2000 Apr; 18(3):277-85. PubMed ID: 10733880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of human IL-6 mutants expressed in Escherichia coli. Biologic activities are not affected by deletion of amino acids 1-28.
    Brakenhoff JP; Hart M; Aarden LA
    J Immunol; 1989 Aug; 143(4):1175-82. PubMed ID: 2663992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function analysis of human IL-6: identification of two distinct regions that are important for receptor binding.
    Hammacher A; Ward LD; Weinstock J; Treutlein H; Yasukawa K; Simpson RJ
    Protein Sci; 1994 Dec; 3(12):2280-93. PubMed ID: 7538847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the C-terminus in the activity, conformation, and stability of interleukin-6.
    Ward LD; Hammacher A; Zhang JG; Weinstock J; Yasukawa K; Morton CJ; Norton RS; Simpson RJ
    Protein Sci; 1993 Sep; 2(9):1472-81. PubMed ID: 8401231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Betaseron.
    Lin L
    Dev Biol Stand; 1998; 96():97-104. PubMed ID: 9890522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody which has the neutralizing activities for human IL-2.
    Sato H; Natsuume-Sakai S; Miyawaki T; Taga K; Hatano M; Taniguchi N
    J Biol Response Mod; 1986 Apr; 5(2):191-201. PubMed ID: 3488373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of natural human interleukin-3.
    Zenke G; Lokker NA; Strittmatter U; Fagg B; Geisse S; Huber-Wegmann G; Kocher HP
    Lymphokine Cytokine Res; 1991 Aug; 10(4):329-35. PubMed ID: 1932378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.